Skip header and navigation

Narrow By

   MORE

54 records – page 1 of 3.

Adjuvant therapy for breast cancer

https://libcat.nshealth.ca/en/permalink/provcat30193
--Boston, MA: Springer-Verlag US , c2009.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Other Authors
Castiglione, Monica
Piccart, Martine J
Place of Publication
Boston, MA
Publisher
Springer-Verlag US
Date of Publication
c2009
Series Vol.
151
Series Title
Cancer treatment and research
ISBN
9780387751153
Subjects (MeSH)
Adjuvants, Pharmaceutic
Breast Neoplasms - therapy
Chemotherapy, Adjuvant
Radiotherapy, Adjuvant
Subjects (LCSH)
Oncology
Gynecology
Format
e-Book
Location
Online
Less detail

Antibiotic and chemotherapy : anti-infective agents and their use in therapy

https://libcat.nshealth.ca/en/permalink/provcat31781
[edited by] Roger Finch ... [et al.]. (9th ed.) --Edinburgh, Scotland: Saunders Elsevier , 2010.
Available Online
View e-Book
Access
Registration required for PDF access.
Location
Online
Available Online
View e-Book
Other Authors
Finch, R. G
Responsibility
[edited by] Roger Finch ... [et al.]
Edition
9th ed.
Place of Publication
Edinburgh, Scotland
Publisher
Saunders Elsevier
Date of Publication
2010
Physical Description
1 online resource (xii, 900 p.)
ISBN
9780702047657
Subjects (MeSH)
Anti-Bacterial Agents - therapeutic use
Infection - drug therapy
Subjects (LCSH)
Anti-infective agents
Antibiotics
Chemotherapy
Anti-Bacterial Agents - therapeutic use
Infection - drug therapy
Contents
pt. 1. General aspects -- pt. 2. Agents -- pt. 3. Treatment.
Access
Registration required for PDF access.
Format
e-Book
Location
Online
Less detail

Brody's human pharmacology : mechanism-based therapeutics

https://libcat.nshealth.ca/en/permalink/provcat31483
[edited by] Lynn Wecker ; with David A. Taylor. (6th ed.) --Philadelphia, PA: Elsevier , c2019.
Available Online
View e-Book
Access
Registration required for PDF access.
Location
Online
Focusing on the essential aspects of pharmacology you need to know, Brody‘s Human Pharmacology, 6th Edition, keeps you fully up to date with all that’s new in the field. Streamlined content, a new organizational approach, enhanced online components, and thoroughly updated information ensure your grasp of key concepts and prepare you for exams. Nearly 500 full-color illustrations explain important processes, while color-coded boxes for major drugs, therapeutic overviews, clinical problems, and …
Available Online
View e-Book
Other Authors
Wecker, Lynn
Responsibility
[edited by] Lynn Wecker ; with David A. Taylor
Edition
6th ed.
Alternate Title
Human pharmacology
Place of Publication
Philadelphia, PA
Publisher
Elsevier
Date of Publication
c2019
Physical Description
1 online resource, 728 p.
ISBN
9780323476522
Subjects (MeSH)
Pharmacology
Pharmacological Phenomena
Subjects (LCSH)
Pharmacology
Chemotherapy
Drug Therapy
Specialty
Pharmacology
Abstract
Focusing on the essential aspects of pharmacology you need to know, Brody‘s Human Pharmacology, 6th Edition, keeps you fully up to date with all that’s new in the field. Streamlined content, a new organizational approach, enhanced online components, and thoroughly updated information ensure your grasp of key concepts and prepare you for exams. Nearly 500 full-color illustrations explain important processes, while color-coded boxes for major drugs, therapeutic overviews, clinical problems, and trade names reinforce your mastery of the information.
Access
Registration required for PDF access.
Format
e-Book
Location
Online
Less detail

Cancer Regional Therapy : HAI, HIPEC, HILP, ILI, PIPAC and Beyond

https://libcat.nshealth.ca/en/permalink/provcat45119
Yuman Fong, T. Clark Gamblin, Ernest S. Han, Byrne Lee, Jonathan S. Zager, editors. --Cham: Springer , c2020.
Available Online
View e-Book
Location
Online
This book is a state-of-the-art overview of cancer regional therapy (CRT) for the surgeons and interventional radiologists active in CRT development and research. The goals of this book are 1) to review the theory and practice of cancer regional therapies including pharmacology, devices, techniques, and workflow, 2) illustrate the most common procedures performed in the interventional and operating rooms, and 3) discuss data supporting use of CRT. This is meant to be a definitive text on the th…
Available Online
View e-Book
Other Authors
Fong, Yuman
Gamblin, T. Clark
Han, Ernest S.
Lee, Byrne
Zager, Jonathan S.
Responsibility
Yuman Fong, T. Clark Gamblin, Ernest S. Han, Byrne Lee, Jonathan S. Zager, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2020
Physical Description
1 online resource (xxvi, 488 p.) : 86 illus., 64 illus. in color
ISBN
9783030288914
9783030288907 (Print ed.)
9783030288921 (Print ed.)
9783030288938 (Print ed.)
Subjects (MeSH)
Chemotherapy, Cancer, Regional Perfusion
Neoplasm Invasiveness - prevention & control
Neoplasm Metastasis
Neoplasms - therapy
Specialty
Medical Oncology
Abstract
This book is a state-of-the-art overview of cancer regional therapy (CRT) for the surgeons and interventional radiologists active in CRT development and research. The goals of this book are 1) to review the theory and practice of cancer regional therapies including pharmacology, devices, techniques, and workflow, 2) illustrate the most common procedures performed in the interventional and operating rooms, and 3) discuss data supporting use of CRT. This is meant to be a definitive text on the theory and practice of CRT. It begins with a summary of the history, technical principles that underlie regional therapy. The following parts discuss current data and practice in peritoneal, liver, limb, pleural and other sites. Included in the practice are considerations of workflow and financial issues revolving around CRT. Novel techniques and therapies under investigation are presented to inform the direction of the field. Cancer Regional Therapy summarizes the history, current technology, common procedures, and future prospects in this field and includes procedures from many surgical and interventional radiologic disciplines.
Contents
Part I. Background -- 1. The Basis of Regional Therapy, Pharmacology, Hyperthermia, and Drug Resistance -- 2. Novel Biological Therapies with Direct Application to the Peritoneal Cavity -- 3. Y-90 Radiomicrosphere Therapy: Principles and Clinical Use in Colorectal Cancer Liver Metastases -- 4. Principles of Percutaneous Ablation in the Liver -- 5. Regional Gene Therapy for Cancer -- Part II. Peritoneal Regional Therapy for Cancer -- 6. Historical Perspective for Regional Peritoneal Therapy: HIPEC, EPIC, and Port-Based Therapy -- 7. Rationale Behind HIPEC/Molecular and Genetic Considerations in HIPEC -- 8 .Data for HIPEC for Pseudomyxoma Peritonei/Tumors of the Appendix -- 9. Data for HIPEC in Colorectal Cancer (T4 Lesions and Metastases) -- 10. Role of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Peritoneal Metastasis of Gastric Cancer -- 11. Regional Therapy for the Treatment of Ovarian Cancer: HIPEC and Intraperitoneal Chemotherapy -- 12. Mesothelioma and Miscellaneous Disease Processes -- Part III. Perioperative Considerations for HIPEC -- 13. Anesthetic Considerations for Regional Therapies -- 14. Postoperative Management of Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy -- 15. Complications of Cytoreductive Surgery and HIPEC -- 16. Liver Resection and HIPEC -- 17. Peritoneal Perfusion Techniques -- 18. Operative Pearls for Cytoreduction of the Difficult Abdomen and Pelvis -- 19. Novel Techniques and the Future of HIPEC (Immunotherapy, Viral Therapy) -- 20. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) -- Part IV. Liver Infusional and Perfusional Therapies -- 21. The History of Isolated Hepatic Perfusion for Liver Metastases and Current Indications for Use -- 22. Pump-Based Hepatic Arterial Infusional Therapy -- 23. Percutaneous Transcatheter Particle Therapies -- 24. Hepatic Perfusion: Surgical and Catheter -- 25. Percutaneous and Port Delivered Arterial Infusional Therapy for Liver Tumors -- 26. Regional Therapies in Hepatocellular Carcinoma and Cholangiocarcinoma -- 27. Regional Therapies for Hepatic Melanoma Metastases -- 28. Complications of Intra-Arterial Regional Liver Therapy -- Part V. Limb Infusional and Perfusional Therapies -- 29. Infusion Technique -- 30. Hyperthermic Isolated Limb Perfusion for Melanoma -- 31. Isolated Limb Perfusion and Infusion in the Management of In-Transit Melanoma of the Extremities: Modern Data Affecting Practice -- 32. Trial Data for Sarcoma -- Part VI. Other Regional Therapies -- 33. Regional Therapy of Bladder Tumors -- 34. Delivery of Antineoplastic Therapeutics to the Central Nervous System -- 35. Intralesional Therapies: Oncolytic Viral Therapies, Immunostimulants -- 36. Ongoing Clinical Trials and Rationale in Regional and Oligometastatic Disease -- 37. Radiation Therapy.
Format
e-Book
Location
Online
Less detail

Cancer related brain fog

https://libcat.nshealth.ca/en/permalink/chpams37382
Nova Scotia Health Authority. Central Zone. Radiation Team, Nova Scotia Health. Cancer Care Program. Halifax, NS: Nova Scotia Health Cancer Care Program , 2022.
Pamphlet Number
4029
Available Online
View Pamphlet
Cancer patients and survivors can be frustrated by the mental cloudiness they notice before, during, and after cancer treatment. This common cancer side effect is called Brain Fog or Chemo Brain. The term Chemo Brain can be misleading as chemotherapy is not the only cause of concentration and memory problems. This pamphlet explains what brain fog is, what causes it, the risk factors for brain fog, and what you can do to manage it. A list of resources for further information is included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Radiation Team
Nova Scotia Health. Cancer Care Program
Alternate Title
Cancer-related brain fog
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Drug-Related Side Effects and Adverse Reactions
Neoplasms - complications
Neoplasms - psychology
Patients - psychology
Subjects (LCSH)
Cancer--Chemotherapy--Complications
Cancer--Patients--Psychology
Specialty
Cancer Care
Abstract
Cancer patients and survivors can be frustrated by the mental cloudiness they notice before, during, and after cancer treatment. This common cancer side effect is called Brain Fog or Chemo Brain. The term Chemo Brain can be misleading as chemotherapy is not the only cause of concentration and memory problems. This pamphlet explains what brain fog is, what causes it, the risk factors for brain fog, and what you can do to manage it. A list of resources for further information is included.
Responsibility
Prepared by: NSH Central Zone Radiation Team
Pamphlet Number
4029
Less detail
IWK. Pharmacy. Halifax, NS: IWK Health Centre , 2019.
Pamphlet Number
PL-1204
Available Online
View Pamphlet
Captopril - This medicine is used to treat high blood pressure and heart failure. Captopril is a medicine that lowers blood pressure and reduces the amount of work the heart has to do.
Available Online
View Pamphlet
Corporate Author
IWK. Pharmacy
Alternate Title
Dissolve-A-Dose® System
Place of Publication
Halifax, NS
Publisher
IWK Health Centre
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document : digital, PDF file
Subjects (MeSH)
Antihypertensive Agents
Captopril
Hypertension - drug therapy
Subjects (LCSH)
Captopril
Hypertension--Chemotherapy
Hypotensive agents
Abstract
Captopril - This medicine is used to treat high blood pressure and heart failure. Captopril is a medicine that lowers blood pressure and reduces the amount of work the heart has to do.
Responsibility
IWK NICU Pharmacy Team, Halifax, NS
Pamphlet Number
PL-1204
Zone
All Zones
Less detail
IWK. Pharmacy. Halifax, NS: IWK Health Centre , 2019.
Pamphlet Number
PL-1205
Available Online
View Pamphlet
Cephalexin is an antibiotic used to treat infection caused by bacteria. It is sometimes used in lower doses to prevent infection.
Available Online
View Pamphlet
Corporate Author
IWK. Pharmacy
Place of Publication
Halifax, NS
Publisher
IWK Health Centre
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document : digital, PDF file
Subjects (MeSH)
Anti-Infective Agents
Cephalexin
Pharmaceutical Preparations
Subjects (LCSH)
Antibiotics
Infection--Treatment
Infection in children--Chemotherapy
Abstract
Cephalexin is an antibiotic used to treat infection caused by bacteria. It is sometimes used in lower doses to prevent infection.
Responsibility
IWK NICU Pharmacy Team, Halifax, NS
Pamphlet Number
PL-1205
Zone
All Zones
Less detail

Cytotoxic Precautions at Home : A Guide for Cancer Patients and Families

https://libcat.nshealth.ca/en/permalink/chpams37335
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2018.
Pamphlet Number
0001
Available Online
View Pamphlet
This pamphlet explains the risks of cytotoxic cancer treatments being taken at home and what precautions must be taken for you and those in contact with you to stay safe. Includes information on storage of the treatment, disposal of waste, interactions with others, and hospital samples.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Antineoplastic Agents - toxicity
Home Nursing
Neoplasms - drug therapy
Patient Safety
Subjects (LCSH)
Antineoplastic agents--Safety measures
Cancer--Chemotherapy--Complications
Home nursing
Patient safety
Specialty
Pharmacy
Self Care
Abstract
This pamphlet explains the risks of cytotoxic cancer treatments being taken at home and what precautions must be taken for you and those in contact with you to stay safe. Includes information on storage of the treatment, disposal of waste, interactions with others, and hospital samples.
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Cancer Care Program
Pamphlet Number
0001
Less detail

Drug interaction facts 2015 : the authority on drug interactions

https://libcat.nshealth.ca/en/permalink/provcat38419
editor, David S. Tatro. --St. Louis, MO: Wolters Kluwer Health , 2015.
Call Number
QV 39 D794 2015
Location
Cape Breton Regional
Call Number
QV 39 D794 2015
Other Authors
Tatro, David S.
Responsibility
editor, David S. Tatro
Place of Publication
St. Louis, MO
Publisher
Wolters Kluwer Health
Date of Publication
2015
Physical Description
lviii, 2486 p.
ISBN
9781574393637 (pbk.)
1574393634 (pbk.)
Subjects (MeSH)
Drug Interactions
Drug Therapy, Combination
Subjects (LCSH)
Drug interactions--Handbooks, manuals, etc.
Chemotherapy, Combination--Handbooks, manuals, etc.
Format
Book
Location
Cape Breton Regional
Less detail

Erythropoieis-stimulating agents (ESAs) for chronic kidney disease (CKD) : with active cancer or a history of cancer or stroke

https://libcat.nshealth.ca/en/permalink/chpams37446
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2217
Available Online
View Pamphlet
Erythropoiesis-stimulating agents (ESAs) are a group of medicines that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This can cause their red blood cell count to drop and anemia (not enough red blood cells or hemoglobin in the blood) to develop. If you have CKD and active cancer or a history of cancer of stroke, it is important to carefully …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Renal insufficiency, chronic - complications
Anemia - drug therapy
Hematinics - therapeutic use
Neoplasms
Stroke
Subjects (LCSH)
Chronic renal failure--Complications
Hematopoietic growth factors
Renal anemia--Chemotherapy
Cancer
Cerebrovascular disease
Abstract
Erythropoiesis-stimulating agents (ESAs) are a group of medicines that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This can cause their red blood cell count to drop and anemia (not enough red blood cells or hemoglobin in the blood) to develop. If you have CKD and active cancer or a history of cancer of stroke, it is important to carefully consider the risks and benefits of ESAs. The risks and benefits of ESAs are listed. Your health care team will talk with you about the risks and benefits of ESAs and other factors to consider when making the decision to take ESAs.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2217
Less detail

Erythropoiesis-stimulating agent (ESA) therapy and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35406
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1493
Available Online
View Pamphlet
Erythropoiesis-stimulating agents (ESAs) are a group of medicines that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This can cause their red blood cell count to drop and anemia (not enough red blood cells or hemoglobin in the blood) to develop. How to take and store this medicine and possible side effects to watch for are reviewed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal insufficiency, chronic - complications
Anemia - drug therapy
Hematinics - therapeutic use
Subjects (LCSH)
Chronic renal failure--Complications
Hematopoietic growth factors
Renal anemia--Chemotherapy
Abstract
Erythropoiesis-stimulating agents (ESAs) are a group of medicines that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This can cause their red blood cell count to drop and anemia (not enough red blood cells or hemoglobin in the blood) to develop. How to take and store this medicine and possible side effects to watch for are reviewed.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1493
Less detail

Extravasation Care for Cancer Patients

https://libcat.nshealth.ca/en/permalink/chpams37383
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2019.
Pamphlet Number
0069
Available Online
View Pamphlet
Instructions for chemotherapy patients who experience extravasation during treatment are outlined.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document : digital, PDF file
Subjects (MeSH)
Extravasation of Diagnostic and Therapeutic Materials
Home Nursing
Neoplasms - drug therapy
Patient Safety
Subjects (LCSH)
Cancer--Chemotherapy--Complications
Home nursing
Patient safety
Specialty
Medical Oncology
Pharmacy
Abstract
Instructions for chemotherapy patients who experience extravasation during treatment are outlined.
Responsibility
prepared by Nova Scotia Health Authority Cancer Care Program
Pamphlet Number
0069
Less detail

From Local Invasion to Metastatic Cancer : Involvement of Distant Sites Through the Lymphovascular System

https://libcat.nshealth.ca/en/permalink/provcat28422
edited by Stanley P. L. Leong. --Totowa, NJ: Humana Press , c2009.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Leong, Stanley P. L
Responsibility
edited by Stanley P. L. Leong
Place of Publication
Totowa, NJ
Publisher
Humana Press
Date of Publication
c2009
Series Title
Current clinical oncology
ISBN
9781603270878
Subjects (MeSH)
Antineoplastic Combined Chemotherapy Protocols
Disease Progression
Lymphangiogenesis - drug effects
Lymphatic Metastasis
Neoplasm Invasiveness
Neovascularization, Pathologic - physiopathology
Format
e-Book
Location
Online
Less detail

General Chemotherapy Information

https://libcat.nshealth.ca/en/permalink/chpams37206
IWK. Hematology / Oncology, IWK. Nephrology. Halifax, NS: IWK Health Centre , 2020.
Pamphlet Number
PL-1105
Available Online
View Pamphlet
Chemotherapy is medicine that treats cancer by stopping cells from growing, or by destroying cells. Several types of chemotherapies may be used. This is because they each stop cell growth or destroy cells in a different way.
Available Online
View Pamphlet
Corporate Author
IWK. Hematology / Oncology
IWK. Nephrology
Alternate Title
IWK Hematology Oncology Service
Place of Publication
Halifax, NS
Publisher
IWK Health Centre
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document : digital, PDF file
Subjects (MeSH)
Antineoplastic Agents
Neoplasms - drug therapy
Subjects (LCSH)
Antineoplastic agents
Chemotherapy
Abstract
Chemotherapy is medicine that treats cancer by stopping cells from growing, or by destroying cells. Several types of chemotherapies may be used. This is because they each stop cell growth or destroy cells in a different way.
Responsibility
IWK Hematology / Oncology, Halifax, NS
Pamphlet Number
PL-1105
Zone
All Zones
Less detail

Getting Chemotherapy by an Infusor® Infusion Pump

https://libcat.nshealth.ca/en/permalink/chpams37389
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Health Authority Cancer Care Program , 2020.
Pamphlet Number
0477
Available Online
View Pamphlet
An Infusor® Infusion Pump is a disposable pump that gives you chemotherapy at home. This pamphlet describes how the pump works and how to use the pump at home.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Health Authority Cancer Care Program
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Infusion Pumps
Neoplasms - drug therapy
Home Infusion Therapy
Subjects (LCSH)
Cancer--Chemotherapy
Drug infusion pumps
Home drug infusion therapy
Specialty
Pharmacy
Self Care
Abstract
An Infusor® Infusion Pump is a disposable pump that gives you chemotherapy at home. This pamphlet describes how the pump works and how to use the pump at home.
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Health Authority Cancer Care Program ; approved by Nova Scotia Cancer Patient Education Committee
Pamphlet Number
0477
Less detail
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2018.
Pamphlet Number
0005
Available Online
View Pamphlet
Hair loss, known as alopecia (pronounced ‘al-o-peesha’), is a common side effect of cancer treatment. This pamphlet includes information on the amount of hair, why it is being lost, if it will grow back, coping mechanisms for hair loss, and questions to ask your health care team.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (3 p.) : digital, PDF file
Subjects (MeSH)
Alopecia
Antineoplastic Agents - adverse effects
Drug-Related Side Effects and Adverse Reactions
Subjects (LCSH)
Antineoplastic agents--Side effects
Baldness
Cancer--Chemotherapy--Complications
Specialty
Self Care
Therapeutics
Abstract
Hair loss, known as alopecia (pronounced ‘al-o-peesha’), is a common side effect of cancer treatment. This pamphlet includes information on the amount of hair, why it is being lost, if it will grow back, coping mechanisms for hair loss, and questions to ask your health care team.
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Cancer Care Program
Pamphlet Number
0005
Less detail

Immune Checkpoint Inhibitors : A Guide for Cancer Patients

https://libcat.nshealth.ca/en/permalink/chpams37419
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2018.
Pamphlet Number
1674
Available Online
View Pamphlet
This guide describes Immune Checkpoint Inhibitors (CPIs), why they are used, differences from other treatments, possible side effects, what precautions to take, and what to expect after treatment.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Immune Checkpoint Inhibitors
Immunotherapy
Neoplasms - drug therapy
Subjects (LCSH)
Cancer--Chemotherapy
Cancer--Immunotherapy
Specialty
Pharmacy
Abstract
This guide describes Immune Checkpoint Inhibitors (CPIs), why they are used, differences from other treatments, possible side effects, what precautions to take, and what to expect after treatment.
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Cancer Care Program
Pamphlet Number
1674
Less detail

Induction Chemotherapy : Systemic and Locoregional

https://libcat.nshealth.ca/en/permalink/provcat40104
Karl Reinhard Aigner, Frederick O. Stephens, editors. (2nd ed.) --Cham: Springer , c2016.
Available Online
View e-Book
Location
Online
This book presents the full range of management techniques and practices used in induction chemotherapy--both systemic and locoregional--by experienced international groups within one accessible volume. It provides the latest information on the pioneering and cutting-edge practices employed in different institutions and documents the advantages of integrated treatment schedules. All those responsible for treating patients with locally advanced cancers may find new, interesting aspects of locore…
Available Online
View e-Book
Other Authors
Aigner, Karl Reinhard
Stephens, Frederick O
Responsibility
Karl Reinhard Aigner, Frederick O. Stephens, editors
Edition
2nd ed.
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2016
Physical Description
1 online resource (vii, 506 p. : 131 illus., 86 illus. in color)
ISBN
9783319287737
9783319287713 (print ed.)
Subjects (MeSH)
Antineoplastic Agents - administration & dosage
Induction Chemotherapy - methods
Infusions, Intra-Arterial - methods
Neoplasms - drug therapy
Remission Induction - methods
Abstract
This book presents the full range of management techniques and practices used in induction chemotherapy--both systemic and locoregional--by experienced international groups within one accessible volume. It provides the latest information on the pioneering and cutting-edge practices employed in different institutions and documents the advantages of integrated treatment schedules. All those responsible for treating patients with locally advanced cancers may find new, interesting aspects of locoregional cancer management and will find this book to be an invaluable source of up-to-date information. Throughout the world, induction chemotherapy is being used as part of an integrated plan of management for locally advanced, solid tumors, while systemic chemotherapy is most commonly used to shrink primarily non-operable tumors. In cases of poorly or nonresponsive tumors, attempts have been made to administer chemotherapeutics via the arterial route in order to achieve higher localized drug exposure and response rates. Such therapies are being practiced worldwide in independent, remote departments in universities, teaching hospitals and clinical schools. Frequently, however, these teams remain relatively unaware of the work being done in other institutions, which may slow further progress.
Contents
Introduction: Overview, History, Terminology and Early Clinical Experience -- The Principle of Dose-Response in Antineoplastic Drug Delivery -- Drug Removal Systems and Induction Chemotherapy -- Cryotherapy -- Local and Regional Hyperthermia -- The Role of Hypoxia and Hyperthermia in Chemotherapy -- Induction Chemotherapy in Head and Neck Cancers -- Isolated Thoracic Perfusion with Carotid Artery Infusion for Advanced and Chemoresistant Tumors of the Parotid Gland -- Induction Chemotherapy For Breast Cancer -- Patients with Locally Advanced Breast Cancer receiving Intra-Arterial Induction Chemotherapy: report of a Phase II Clinical Study -- Regional Chemotherapy with Thoracic Wall Recurrence and Metastasized Breast Cancer -- Cytoreductive Surgery and ÇHyperthermic Intraperitoneal Chemotherapy-HIPEC -- Induction Bidirectional Chemotherapy for Gastric Cancer with Peritoneal Dissemination -- Esophageal Cancer -- Gastric Cancer -- Systemic and Regional Chemotherapy for Advanced and Metastasized Pancreatic Cancer -- Interventional Radiological Procedures for Port-Catheter Implantation -- Induction chemotherapy for hepatocellular carcinoma -- Transarterial Treatment of Primary and Secondary Liver Tumors -- Pelvic Perfusion for Rectal Cancer -- Isolated Pelvic Perfusion with Chemofiltration for Pelvic Malignancies: Anal, Cervical and Bladder Cancer -- Penile cancer treated by intra-arterial infusion chemotherapy -- Systemic Induction Chemotherapy for Advanced Stage Epithelial Ovarian Cancer -- Regional Chemotherapy in Recurrent Platinum-Refractory Ovarian Cancer -- Isolated Limb Perfusion for Melanoma -- Isolated Limb Infusion -- Induction treatment in sarcomas -- Isolated Limb Perfusion for Locally Advanced Soft Tissue Sarcoma -- Induction Chemotherapy in Treatment of Sarcomas -- Isolation Perfusion Systems: Lungs -- Metastatic Cancers in Lung: Isolated Lung Perfusio: Clinical Studies -- Isolated Thoracic Perfusion with Chemofiltration (ITP-F) for Advanced and Pre-treated Non-Small-Cell Lung Cancer -- Toxicity Profiles with Systemic versus Regional Chemotherapy.
Format
e-Book
Location
Online
Less detail

[In French] Instructions pour préparer et administrer une chimiothérapie par voie orale

https://libcat.nshealth.ca/en/permalink/chpams37232
IWK. Hematology / Oncology, IWK. Nephrology. Halifax, NS: IWK Health Centre , 2019.
Pamphlet Number
PL-1106-FR
Available Online
View Pamphlet
In French. La chimiothérapie est un ensemble de médicaments qui traitent le cancer. Ces médicaments peuvent détruire les cellules cancéreuses ou les empêcher de croître. Bien que le risque de danger à manipuler des médicaments chimiothérapiques soit faible, il est bon d’éviter l’exposition à ces médicaments. / Depending on the complexity of your child’s care, tests and clinic visits may be scheduled over 2 or more days. This may not include test/scan results. The staff at the IWK work hard to …
Available Online
View Pamphlet
Corporate Author
IWK. Hematology / Oncology
IWK. Nephrology
Alternate Title
si votre enfant prend un médicament chimiothérapique liquide
Instructions for Preparing and giving Chemotherapy by Mouth
If your child’s dose is in Liquid form
Place of Publication
Halifax, NS
Publisher
IWK Health Centre
Date of Publication
2019
Format
Pamphlet
Language
French
Physical Description
1 electronic document : digital, PDF file
Subjects (MeSH)
Administration, Oral
Antineoplastic Agents
Neoplasms - drug therapy
Pharmaceutical Preparations
Subjects (LCSH)
Cancer--Chemotherapy
Abstract
In French. La chimiothérapie est un ensemble de médicaments qui traitent le cancer. Ces médicaments peuvent détruire les cellules cancéreuses ou les empêcher de croître. Bien que le risque de danger à manipuler des médicaments chimiothérapiques soit faible, il est bon d’éviter l’exposition à ces médicaments. / Depending on the complexity of your child’s care, tests and clinic visits may be scheduled over 2 or more days. This may not include test/scan results. The staff at the IWK work hard to schedule and accommodate your child’s needs as best as possible in order to limit the amount of time you spend at the health centre.
Responsibility
IWK Hematology / Oncology, Halifax, NS
Pamphlet Number
PL-1106-FR
Zone
All Zones
Less detail

[In French] Instructions pour préparer et administrer une chimiothérapie par voie orale

https://libcat.nshealth.ca/en/permalink/chpams37233
IWK. Hematology / Oncology, IWK. Nephrology. Halifax, NS: IWK Health Centre , 2019.
Pamphlet Number
PL-1107-FR
Available Online
View Pamphlet
In French. La chimiothérapie est un ensemble de médicaments qui traitent le cancer. Ces médicaments peuvent détruire les cellules cancéreuses ou les empêcher de croître. Bien que le risque de danger à manipuler des médicaments chimiothérapiques soit faible, il est bon d’éviter l’exposition à ces médicaments. / Depending on the complexity of your child’s care, tests and clinic visits may be scheduled over 2 or more days. This may not include test/scan results. The staff at the IWK work hard to s…
Available Online
View Pamphlet
Corporate Author
IWK. Hematology / Oncology
IWK. Nephrology
Alternate Title
si vous devez ouvrir des capsules
Instructions for Preparing and giving Chemotherapy by Mouth
Opening Capsules
Place of Publication
Halifax, NS
Publisher
IWK Health Centre
Date of Publication
2019
Format
Pamphlet
Language
French
Physical Description
1 electronic document : digital, PDF file
Subjects (MeSH)
Administration, Oral
Antineoplastic Agents
Neoplasms - drug therapy
Pharmaceutical Preparations
Subjects (LCSH)
Cancer--Chemotherapy
Abstract
In French. La chimiothérapie est un ensemble de médicaments qui traitent le cancer. Ces médicaments peuvent détruire les cellules cancéreuses ou les empêcher de croître. Bien que le risque de danger à manipuler des médicaments chimiothérapiques soit faible, il est bon d’éviter l’exposition à ces médicaments. / Depending on the complexity of your child’s care, tests and clinic visits may be scheduled over 2 or more days. This may not include test/scan results. The staff at the IWK work hard to schedule and accommodate your child’s needs as best as possible in order to limit the amount of time you spend at the health centre.
Responsibility
IWK Hematology / Oncology, Halifax, NS
Pamphlet Number
PL-1107-FR
Zone
All Zones
Less detail

54 records – page 1 of 3.